Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 20 studies | 39% ± 20% | |
lung | 19 studies | 39% ± 13% | |
peripheral blood | 18 studies | 36% ± 18% | |
intestine | 11 studies | 37% ± 21% | |
eye | 10 studies | 38% ± 17% | |
kidney | 9 studies | 31% ± 8% | |
liver | 6 studies | 42% ± 18% | |
uterus | 5 studies | 50% ± 17% | |
adipose | 5 studies | 33% ± 10% | |
lymph node | 5 studies | 42% ± 13% | |
breast | 5 studies | 44% ± 17% | |
pancreas | 4 studies | 42% ± 9% | |
placenta | 4 studies | 34% ± 9% | |
bone marrow | 4 studies | 40% ± 17% | |
heart | 4 studies | 27% ± 3% | |
esophagus | 4 studies | 32% ± 23% | |
prostate | 4 studies | 28% ± 7% | |
thymus | 3 studies | 53% ± 19% | |
skin | 3 studies | 36% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 18643.19 | 21 / 21 | 100% | 140.07 | 504 / 504 |
breast | 100% | 24139.29 | 459 / 459 | 100% | 155.33 | 1118 / 1118 |
esophagus | 100% | 17180.77 | 1445 / 1445 | 100% | 131.94 | 183 / 183 |
intestine | 100% | 19095.63 | 966 / 966 | 100% | 129.54 | 527 / 527 |
lung | 100% | 18670.81 | 578 / 578 | 100% | 130.37 | 1155 / 1155 |
ovary | 100% | 31710.93 | 180 / 180 | 100% | 113.63 | 430 / 430 |
pancreas | 100% | 13267.49 | 328 / 328 | 100% | 97.19 | 178 / 178 |
prostate | 100% | 21216.19 | 245 / 245 | 100% | 135.97 | 502 / 502 |
stomach | 100% | 15586.33 | 359 / 359 | 100% | 117.46 | 286 / 286 |
thymus | 100% | 21840.52 | 653 / 653 | 100% | 128.65 | 605 / 605 |
uterus | 100% | 24855.21 | 170 / 170 | 100% | 169.32 | 459 / 459 |
brain | 99% | 14712.87 | 2621 / 2642 | 100% | 142.45 | 705 / 705 |
skin | 100% | 26227.82 | 1809 / 1809 | 99% | 133.70 | 468 / 472 |
kidney | 100% | 14166.27 | 89 / 89 | 99% | 87.33 | 890 / 901 |
liver | 100% | 8766.51 | 226 / 226 | 98% | 59.16 | 397 / 406 |
adrenal gland | 100% | 17699.78 | 258 / 258 | 97% | 71.75 | 223 / 230 |
adipose | 100% | 22506.81 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 168.77 | 29 / 29 |
spleen | 100% | 22311.53 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 149.75 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 80.80 | 1 / 1 |
blood vessel | 100% | 16789.79 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 11941.92 | 800 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 10912.59 | 848 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 70.23 | 77 / 80 |
peripheral blood | 92% | 12471.92 | 851 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006397 | Biological process | mRNA processing |
GO_0045087 | Biological process | innate immune response |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0006338 | Biological process | chromatin remodeling |
GO_0042752 | Biological process | regulation of circadian rhythm |
GO_0000380 | Biological process | alternative mRNA splicing, via spliceosome |
GO_0000724 | Biological process | double-strand break repair via homologous recombination |
GO_0042754 | Biological process | negative regulation of circadian rhythm |
GO_0008380 | Biological process | RNA splicing |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0002218 | Biological process | activation of innate immune response |
GO_1902177 | Biological process | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway |
GO_0048511 | Biological process | rhythmic process |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016363 | Cellular component | nuclear matrix |
GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
GO_0005829 | Cellular component | cytosol |
GO_0042382 | Cellular component | paraspeckles |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0003682 | Molecular function | chromatin binding |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0042826 | Molecular function | histone deacetylase binding |
Gene name | SFPQ |
Protein name | Splicing factor proline and glutamine rich Splicing factor proline/glutamine-rich (Polypyrimidine tract binding protein associated) SFPQ protein Splicing factor, proline- and glutamine-rich (100 kDa DNA-pairing protein) (hPOMp100) (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor) |
Synonyms | PSF |
Description | FUNCTION: DNA- and RNA binding protein, involved in several nuclear processes. Essential pre-mRNA splicing factor required early in spliceosome formation and for splicing catalytic step II, probably as a heteromer with NONO. Binds to pre-mRNA in spliceosome C complex, and specifically binds to intronic polypyrimidine tracts. Involved in regulation of signal-induced alternative splicing. During splicing of PTPRC/CD45, a phosphorylated form is sequestered by THRAP3 from the pre-mRNA in resting T-cells; T-cell activation and subsequent reduced phosphorylation is proposed to lead to release from THRAP3 allowing binding to pre-mRNA splicing regulatotry elements which represses exon inclusion. Interacts with U5 snRNA, probably by binding to a purine-rich sequence located on the 3' side of U5 snRNA stem 1b. May be involved in a pre-mRNA coupled splicing and polyadenylation process as component of a snRNP-free complex with SNRPA/U1A. The SFPQ-NONO heteromer associated with MATR3 may play a role in nuclear retention of defective RNAs. SFPQ may be involved in homologous DNA pairing; in vitro, promotes the invasion of ssDNA between a duplex DNA and produces a D-loop formation. The SFPQ-NONO heteromer may be involved in DNA unwinding by modulating the function of topoisomerase I/TOP1; in vitro, stimulates dissociation of TOP1 from DNA after cleavage and enhances its jumping between separate DNA helices. The SFPQ-NONO heteromer binds DNA . The SFPQ-NONO heteromer may be involved in DNA non-homologous end joining (NHEJ) required for double-strand break repair and V(D)J recombination and may stabilize paired DNA ends; in vitro, the complex strongly stimulates DNA end joining, binds directly to the DNA substrates and cooperates with the Ku70/G22P1-Ku80/XRCC5 (Ku) dimer to establish a functional preligation complex. SFPQ is involved in transcriptional regulation. Functions as a transcriptional activator . Transcriptional repression is mediated by an interaction of SFPQ with SIN3A and subsequent recruitment of histone deacetylases (HDACs). The SFPQ-NONO-NR5A1 complex binds to the CYP17 promoter and regulates basal and cAMP-dependent transcriptional activity. SFPQ isoform Long binds to the DNA binding domains (DBD) of nuclear hormone receptors, like RXRA and probably THRA, and acts as a transcriptional corepressor in absence of hormone ligands. Binds the DNA sequence 5'-CTGAGTC-3' in the insulin-like growth factor response element (IGFRE) and inhibits IGF-I-stimulated transcriptional activity. Regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-BMAL1 heterodimer. Required for the transcriptional repression of circadian target genes, such as PER1, mediated by the large PER complex through histone deacetylation (By similarity). Required for the assembly of nuclear speckles . Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway . . |
Accessions | ENST00000460428.5 Q9BSV4 Q86VG2 P23246 H0Y9K7 Q6PIX2 H0Y9U2 A0A8Q3WMA7 ENST00000470472.5 ENST00000357214.6 [P23246-1] ENST00000696553.1 |